Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	low voltage-gated calcium channel activity	CACNA1I CACNA1G	6.56e-05	3	94	2	GO:0008332
GeneOntologyCellularComponent	photoreceptor connecting cilium	MYO7A CETN1 CETN2 RP1L1	6.15e-05	48	93	4	GO:0032391
GeneOntologyCellularComponent	postsynaptic density	VHL STRN ATP7A DBNL PSD3 MACF1 EEF2K CLSTN2 PIP5K1C	1.81e-04	451	93	9	GO:0014069
GeneOntologyCellularComponent	transcription export complex 2	CETN2 MCM3AP	1.94e-04	5	93	2	GO:0070390
GeneOntologyCellularComponent	asymmetric synapse	VHL STRN ATP7A DBNL PSD3 MACF1 EEF2K CLSTN2 PIP5K1C	2.74e-04	477	93	9	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	VHL STRN ATP7A DBNL PSD3 MACF1 EEF2K CLSTN2 PIP5K1C	4.04e-04	503	93	9	GO:0099572
GeneOntologyCellularComponent	ciliary transition zone	MYO7A CETN1 CETN2 RP1L1	4.70e-04	81	93	4	GO:0035869
GeneOntologyCellularComponent	neuron to neuron synapse	VHL STRN ATP7A DBNL PSD3 MACF1 EEF2K CLSTN2 PIP5K1C	5.35e-04	523	93	9	GO:0098984
Domain	LIM-bd/SEUSS	LDB1 LDB2	2.51e-05	2	94	2	IPR029005
Domain	VDCC_T_a1	CACNA1I CACNA1G	7.49e-05	3	94	2	IPR005445
Domain	EF-hand_1	CETN1 CETN2 CABP4 MACF1 RCN3 RYR2	1.19e-04	152	94	6	PF00036
Domain	EFh	CETN1 CETN2 CABP4 MACF1 RCN3 RYR2	1.47e-04	158	94	6	SM00054
Domain	-	CETN1 CETN2 CABP4 RHBDL1 MACF1 RCN3 RYR2	3.49e-04	261	94	7	1.10.238.10
Domain	EF-hand-dom_pair	CETN1 CETN2 CABP4 RHBDL1 MACF1 RCN3 RYR2	6.16e-04	287	94	7	IPR011992
Domain	EF-hand_8	CETN1 RCN3 RYR2	6.60e-04	34	94	3	PF13833
Domain	MYTH4	MYO7A MYO7B	8.82e-04	9	94	2	PS51016
Domain	MyTH4	MYO7A MYO7B	8.82e-04	9	94	2	SM00139
Domain	MyTH4_dom	MYO7A MYO7B	8.82e-04	9	94	2	IPR000857
Domain	MyTH4	MYO7A MYO7B	8.82e-04	9	94	2	PF00784
Domain	EF-hand_7	CETN1 CETN2 CABP4 MACF1	8.92e-04	85	94	4	PF13499
Domain	VDCCAlpha1	CACNA1I CACNA1G	1.10e-03	10	94	2	IPR002077
Domain	EF_HAND_2	CETN1 CETN2 CABP4 MACF1 RCN3 RYR2	1.10e-03	231	94	6	PS50222
Domain	EF_hand_dom	CETN1 CETN2 CABP4 MACF1 RCN3 RYR2	1.13e-03	232	94	6	IPR002048
Domain	PH_dom-like	NET1 MYO7A MYO7B KIF1B PSD3 FRS2 ARHGEF4 LYST	1.38e-03	426	94	8	IPR011993
Domain	EF_Hand_1_Ca_BS	CETN1 CETN2 CABP4 MACF1 RCN3	1.91e-03	175	94	5	IPR018247
Domain	-	NET1 MYO7A MYO7B KIF1B PSD3 FRS2 ARHGEF4	3.59e-03	391	94	7	2.30.29.30
Domain	RUN	DENND5A RUBCN	3.64e-03	18	94	2	SM00593
Domain	EF_HAND_1	CETN1 CETN2 CABP4 MACF1 RCN3	3.70e-03	204	94	5	PS00018
Domain	RUN	DENND5A RUBCN	4.05e-03	19	94	2	PS50826
Domain	RUN	DENND5A RUBCN	4.05e-03	19	94	2	PF02759
Domain	Run_dom	DENND5A RUBCN	4.05e-03	19	94	2	IPR004012
Domain	SH3	MYO7A MYO7B DBNL MACF1 ARHGEF4	4.71e-03	216	94	5	PS50002
Domain	SH3_domain	MYO7A MYO7B DBNL MACF1 ARHGEF4	5.09e-03	220	94	5	IPR001452
Domain	Spectrin	SYNE3 MACF1	5.92e-03	23	94	2	PF00435
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RHPN1 NHSL1 SYNE3 WIZ MYO7A FANCI SPEG CSAD MCM3AP CARD10 ARHGEF4 DENND5A FHIP1B PIP5K1C LYST TFE3	4.35e-08	1105	94	16	35748872
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	NHSL1 NEFL CACTIN KRT16 WIZ SUPT5H FANCI CRLF3 SVIL DHX38 DUSP8 PSD3 KRI1 SPAG9 NUDC	1.42e-07	1049	94	15	27880917
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SPEG KIF1B MCM3AP PSD3 MACF1 ARHGEF4 FHIP1B PIP5K1C RUBCN SLC9A6	1.63e-07	407	94	10	12693553
Pubmed	Functional proteomics mapping of a human signaling pathway.	VHL STRN NPR1 LDB1 SUPT5H MCM3AP MACF1 RUBCN RYR2 LDB2	4.68e-06	591	94	10	15231748
Pubmed	An investigation into the human serum "interactome".	KRT16 MACF1 GJC2 CACNA1I F2 RYR2	5.40e-06	162	94	6	15174051
Pubmed	Caspase recruitment domain family member 10 regulates carbamoyl phosphate synthase 1 and promotes cancer growth in bladder cancer cells.	CARD10 CPS1	7.23e-06	2	94	2	31565867
Pubmed	Placental expression of striatin & endothelial nitric oxide synthase in women with & without pre-eclampsia.	STRN NOS3	7.23e-06	2	94	2	37147942
Pubmed	alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice.	CACNA1G NOS3	7.23e-06	2	94	2	19920353
Pubmed	Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.	YAP1 TFE3	7.23e-06	2	94	2	23737213
Pubmed	Contribution of postsynaptic T-type calcium channels to parallel fibre-Purkinje cell synaptic responses.	CACNA1I CACNA1G	7.23e-06	2	94	2	26627919
Pubmed	pVHL promotes lysosomal degradation of YAP in lung adenocarcinoma.	VHL YAP1	7.23e-06	2	94	2	33823241
Pubmed	Testis-specific murine centrin, Cetn1: genomic characterization and evidence for retroposition of a gene encoding a centrosome protein.	CETN1 CETN2	7.23e-06	2	94	2	10486202
Pubmed	Transcriptional control of human adipose tissue blood flow.	NPR1 NOS3	7.23e-06	2	94	2	19165164
Pubmed	Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation.	SPEG RYR2	7.23e-06	2	94	2	32683896
Pubmed	Spliced isoforms of LIM-domain-binding protein (CLIM/NLI/Ldb) lacking the LIM-interaction domain.	LDB1 LDB2	7.23e-06	2	94	2	16815859
Pubmed	YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.	YAP1 TFE3	7.23e-06	2	94	2	34381186
Pubmed	Cloning and chromosomal localization of two novel human genes encoding LIM-domain binding factors CLIM1 and CLIM2/LDB1/NLI.	LDB1 LDB2	7.23e-06	2	94	2	9799849
Pubmed	Elevated neurofilament light chain (NFL) mRNA levels in prediabetic peripheral neuropathy.	NEFL ENO2	7.23e-06	2	94	2	24733614
Pubmed	Characterization of spinal hemangioblastomas in patients with and without von Hippel-Lindau, and YAP expression.	VHL YAP1	7.23e-06	2	94	2	38971615
Pubmed	cDNA sequence for mouse caltractin.	CETN1 CETN2	7.23e-06	2	94	2	8218402
Pubmed	YAP1-TFE3 gene fusion variant in clear cell stromal tumour of lung: report of two cases in support of a distinct entity.	YAP1 TFE3	7.23e-06	2	94	2	34156713
Pubmed	Expression of centrin isoforms in the mammalian retina.	CETN1 CETN2	7.23e-06	2	94	2	9665797
Pubmed	Characterization of the X-linked murine centrin Cetn2 gene.	CETN1 CETN2	7.23e-06	2	94	2	11250075
Pubmed	Isolation and chromosomal assignment of human genes encoding cofactor of LIM homeodomain proteins, CLIM1 and CLIM2.	LDB1 LDB2	7.23e-06	2	94	2	10083735
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	BUD23 SUPT5H YAP1 FANCI EXD2 DBNL CHD9 SPAG9 MFSD1 RUBCN NT5C LRRC41	7.54e-06	925	94	12	28986522
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	SUPT5H YAP1 FANCI KIF1B DHX38 SEC23IP DBNL MCM2 MACF1 EEF2K SPAG9 TUT1 NUDC ENO2 PGGT1B	8.14e-06	1455	94	15	22863883
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	RNF121 ATP7A KRT16 WIZ EXD2 KIF1B SEC23IP FRS2 EEF2K SPAG9 RYR2	8.27e-06	777	94	11	35844135
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CACTIN SETD2 ZNF526 WIZ NET1 ZNF212 MCM3AP EMILIN3 MACF1 CHD9 CAVIN1 CLSTN2 LRRC41	9.69e-06	1116	94	13	31753913
Pubmed	The LMO2 oncogene regulates DNA replication in hematopoietic cells.	CACTIN LDB1 DENND5A PCK1	1.90e-05	58	94	4	26764384
Pubmed	Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C.	CACNA1I CACNA1G	2.16e-05	3	94	2	23488970
Pubmed	Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice.	NPR1 NOS3	2.16e-05	3	94	2	15793309
Pubmed	Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart.	CACNA1I CACNA1G	2.16e-05	3	94	2	11230107
Pubmed	Homeostatic plasticity and burst activity are mediated by hyperpolarization-activated cation currents and T-type calcium channels in neuronal cultures.	CACNA1I CACNA1G	2.16e-05	3	94	2	33547341
Pubmed	ENO2 Promotes Colorectal Cancer Metastasis by Interacting with the LncRNA CYTOR and Activating YAP1-Induced EMT.	YAP1 ENO2	2.16e-05	3	94	2	35954207
Pubmed	Calmodulin regulates Cav3 T-type channels at their gating brake.	CACNA1I CACNA1G	2.16e-05	3	94	2	28972185
Pubmed	Cofactors of LIM Domains Associate with Estrogen Receptor α to Regulate the Expression of Noncoding RNA H19 and Corneal Epithelial Progenitor Cell Function.	LDB1 LDB2	2.16e-05	3	94	2	27129775
Pubmed	Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.	NOS3 RYR2	2.16e-05	3	94	2	18077344
Pubmed	Growth differentiation factor-15 promotes glutamate release in medial prefrontal cortex of mice through upregulation of T-type calcium channels.	CACNA1I CACNA1G	2.16e-05	3	94	2	27353765
Pubmed	Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins.	LDB1 LDB2	2.16e-05	3	94	2	8918878
Pubmed	Differential expression and cellular distribution of centrin isoforms during human ciliated cell differentiation in vitro.	CETN1 CETN2	2.16e-05	3	94	2	10725219
Pubmed	Alpha(1H) mRNA in single skeletal muscle fibres accounts for T-type calcium current transient expression during fetal development in mice.	CACNA1I CACNA1G	2.16e-05	3	94	2	11897840
Pubmed	The expression pattern of Von Hippel-Lindau tumor suppressor protein, MET proto-oncogene, and TFE3 transcription factor oncoprotein in renal cell carcinoma in Upper Egypt.	VHL TFE3	2.16e-05	3	94	2	21299348
Pubmed	T-type channels: release a brake, engage a gear.	CACNA1I CACNA1G	2.16e-05	3	94	2	26488564
Pubmed	Differential interactions of Na+ channel toxins with T-type Ca2+ channels.	CACNA1I CACNA1G	2.16e-05	3	94	2	18591418
Pubmed	Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.	CACNA1I CACNA1G	2.16e-05	3	94	2	28846697
Pubmed	Global genetic deletion of CaV3.3 channels facilitates anaesthetic induction and enhances isoflurane-sparing effects of T-type calcium channel blockers.	CACNA1I CACNA1G	2.16e-05	3	94	2	33299036
Pubmed	Specific contribution of human T-type calcium channel isotypes (alpha(1G), alpha(1H) and alpha(1I)) to neuronal excitability.	CACNA1I CACNA1G	2.16e-05	3	94	2	11927664
Pubmed	PDE5 inhibitor efficacy is estrogen dependent in female heart disease.	NPR1 NOS3	2.16e-05	3	94	2	24837433
Pubmed	The Ldb1 and Ldb2 transcriptional cofactors interact with the Ste20-like kinase SLK and regulate cell migration.	LDB1 LDB2	2.16e-05	3	94	2	19675209
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ZC3H7A SETD2 STRN SUPT5H YAP1 KIF1B MCM3AP DHX38 MACF1	3.15e-05	588	94	9	38580884
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ZC3H7A NEFL STRN COPZ2 KRT16 CETN2 SEC23IP DBNL SKIDA1 MACF1 ARHGEF4 LYST PCK1 RYR2	3.26e-05	1442	94	14	35575683
Pubmed	Genome-wide YFP fluorescence complementation screen identifies new regulators for telomere signaling in human cells.	NEFL SUPT5H DHX38 DBNL MCM2 NUDC ENO2	3.28e-05	330	94	7	21044950
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SETBP1 PSD3 MACF1 CACNA1G SPAG9 ARHGEF4	3.47e-05	225	94	6	12168954
Pubmed	Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy.	CACNA1I CACNA1G	4.32e-05	4	94	2	28165634
Pubmed	TAZ-CAMTA1 and YAP-TFE3 alter the TAZ/YAP transcriptome by recruiting the ATAC histone acetyltransferase complex.	YAP1 TFE3	4.32e-05	4	94	2	33913810
Pubmed	The physical and genetic map surrounding the Lyst gene on mouse chromosome 13.	LYST RYR2	4.32e-05	4	94	2	9070932
Pubmed	NO synthase-II is transiently expressed in embryonic mouse olfactory receptor neurons.	ENO2 NOS3	4.32e-05	4	94	2	9237484
Pubmed	TFEB regulates lysosomal positioning by modulating TMEM55B expression and JIP4 recruitment to lysosomes.	SPAG9 TFE3	4.32e-05	4	94	2	29146937
Pubmed	Muscarinic-dependent phosphorylation of the cardiac ryanodine receptor by protein kinase G is mediated by PI3K-AKT-nNOS signaling.	NOS3 RYR2	4.32e-05	4	94	2	32580946
Pubmed	The estrogen hypothesis of schizophrenia implicates glucose metabolism: association study in three independent samples.	ENO2 PCK1	4.32e-05	4	94	2	18460190
Pubmed	Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor alpha.	STRN NOS3	4.32e-05	4	94	2	15569929
Pubmed	Long-chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action.	CPS1 PCK1	4.32e-05	4	94	2	8985169
Pubmed	ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress.	SETD2 SUPT5H MCM2	4.75e-05	26	94	3	34162889
Pubmed	Identification of differentially expressed genes in mouse spermatogenesis.	MYO7B CETN2 HERPUD2	5.34e-05	27	94	3	14581517
Pubmed	Conserved Mitotic Phosphorylation of a Proteasome Subunit Regulates Cell Proliferation.	STRN LDB1 SUPT5H SEC23IP	6.76e-05	80	94	4	34831298
Pubmed	Differential expression and interaction with the visual G-protein transducin of centrin isoforms in mammalian photoreceptor cells.	CETN1 CETN2	7.19e-05	5	94	2	15347651
Pubmed	MTHFR C677T, FII G20210A, FV Leiden G1691A, NOS3 intron 4 VNTR, and APOE epsilon4 gene polymorphisms are not associated with spontaneous cervical artery dissection.	F2 NOS3	7.19e-05	5	94	2	20446941
Pubmed	ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress.	FANCI MCM2	7.19e-05	5	94	2	25843623
Pubmed	Isl1 and Ldb co-regulators of transcription are essential early determinants of mouse limb development.	LDB1 LDB2	7.19e-05	5	94	2	22411555
Pubmed	Mouse deformed epidermal autoregulatory factor 1 recruits a LIM domain factor, LMO-4, and CLIM coregulators.	LDB1 LDB2	7.19e-05	5	94	2	9860983
Pubmed	HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET.	CETN1 CETN2	7.19e-05	5	94	2	16101678
Pubmed	A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis.	VHL YAP1	7.19e-05	5	94	2	35937460
Pubmed	Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging features and mutations.	VHL SETD2	7.19e-05	5	94	2	24029645
Pubmed	Genetic risk factors for arterial ischemic stroke in children: a possible MTHFR and eNOS gene-gene interplay?	F2 NOS3	7.19e-05	5	94	2	19372095
Pubmed	Light-dependent CK2-mediated phosphorylation of centrins regulates complex formation with visual G-protein.	CETN1 CETN2	7.19e-05	5	94	2	18269917
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	STRN NET1 CETN1 YAP1 CETN2 FANCI DHX38 KRI1 MCM2 TUT1 NUDC	8.61e-05	1005	94	11	19615732
Pubmed	Hypoxia-inducible factor 2α (HIF-2α) promotes colon cancer growth by potentiating Yes-associated protein 1 (YAP1) activity.	VHL YAP1	1.08e-04	6	94	2	28848049
Pubmed	Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women.	F2 NOS3	1.08e-04	6	94	2	15879922
Pubmed	Genetic risk factors for placental abruption: a HuGE review and meta-analysis.	F2 NOS3	1.08e-04	6	94	2	18277167
Pubmed	A family of LIM domain-associated cofactors confer transcriptional synergism between LIM and Otx homeodomain proteins.	LDB1 LDB2	1.08e-04	6	94	2	9192866
Pubmed	The human TREX-2 complex is stably associated with the nuclear pore basket.	CETN2 MCM3AP	1.08e-04	6	94	2	23591820
Pubmed	Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG.	F2 NOS3	1.08e-04	6	94	2	19691831
Pubmed	PtdIns(4,5)P2 signaling regulates ATG14 and autophagy.	PIP5K1C RUBCN	1.08e-04	6	94	2	27621469
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	NHSL1 NET1 YAP1 KIF1B SVIL DBNL PSD3 MACF1 ARHGEF4 LYST	1.14e-04	861	94	10	36931259
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	CACTIN WIZ SUPT5H DHX38 KRI1 DENND5A	1.23e-04	283	94	6	30585729
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NHSL1 NEFL STRN KRT16 MYO7A KIF1B SVIL DBNL PSD3 MACF1 GJC2 ARHGEF4 ENO2	1.25e-04	1431	94	13	37142655
Pubmed	Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation.	STRN LDB1 MCM2 SPAG9 NUDC	1.33e-04	180	94	5	30110629
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	NHSL1 ATP7A SEC23IP PSD3 FRS2 MCM2 MACF1	1.50e-04	421	94	7	36976175
Pubmed	A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis.	F2 NOS3	1.50e-04	7	94	2	19210273
Pubmed	Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study.	F2 NOS3	1.50e-04	7	94	2	15120696
Pubmed	PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells.	F2 NOS3	1.50e-04	7	94	2	26457757
Pubmed	Varying mechanical forces drive sensory epithelium formation.	MYO7A YAP1	1.50e-04	7	94	2	37922362
Pubmed	Deficiency of large tumor suppressor kinase 1 causes congenital hearing loss associated with cochlear abnormalities in mice.	MYO7A YAP1	1.50e-04	7	94	2	33162027
Pubmed	Tails of unconventional myosins.	MYO7A MYO7B	1.50e-04	7	94	2	11212352
Pubmed	Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women.	F2 NOS3	1.50e-04	7	94	2	12468767
Pubmed	Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.	F2 NOS3	1.50e-04	7	94	2	15831156
Pubmed	Mammalian RanBP1 regulates centrosome cohesion during mitosis.	CETN1 CETN2	1.50e-04	7	94	2	12840069
Pubmed	Organ of Corti size is governed by Yap/Tead-mediated progenitor self-renewal.	MYO7A YAP1	1.50e-04	7	94	2	32482884
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	CACNA1I CACNA1G RYR2	1.51e-04	38	94	3	30786075
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	VHL PKIG CACTIN STRN YAP1 FANCI KIF1B DHX38 DBNL SPAG9 NUDC TFE3	1.78e-04	1284	94	12	17353931
Interaction	CALM1 interactions	STRN NET1 MYO7A CETN1 YAP1 CETN2 KIF1B MCM3AP SVIL MCM2 LYST NOS3 PCK1 RYR2 TFE3	1.97e-07	626	94	15	int:CALM1
Interaction	CETN1 interactions	LDB1 CETN1 CETN2 KIF1B MCM3AP	1.13e-05	63	94	5	int:CETN1
Interaction	TOP3B interactions	RHPN1 NHSL1 ZC3H7A SYNE3 WIZ MYO7A FANCI SPEG CSAD KIF1B MCM3AP SVIL CARD10 PATL1 ARHGEF4 DENND5A FHIP1B PIP5K1C LYST TFE3	1.17e-05	1470	94	20	int:TOP3B
Interaction	NUP43 interactions	CACTIN SETD2 CETN2 FANCI MCM3AP DBNL KRI1 CHD9 CAVIN1 CLSTN2 NUDC RYR2	3.34e-05	625	94	12	int:NUP43
Interaction	SGSM1 interactions	CETN1 CETN2 FANCI	3.45e-05	14	94	3	int:SGSM1
Interaction	HOOK3 interactions	ZC3H7A STRN KIF1B KRI1 PATL1 FHIP1B RUBCN	4.49e-05	202	94	7	int:HOOK3
Interaction	YWHAQ interactions	NHSL1 YAP1 SPEG KIF1B SVIL PSD3 MCM2 MACF1 SPAG9 TUT1 ARHGEF4 CPS1 F2 LYST PCK1 TFE3	5.55e-05	1118	94	16	int:YWHAQ
Interaction	UBN2 interactions	SUPT5H YAP1 DBNL MCM2 TFE3	6.04e-05	89	94	5	int:UBN2
GeneFamily	A-kinase anchoring proteins\|Myosins, class VII\|Deafness associated genes\|FERM domain containing	MYO7A MYO7B	1.01e-05	2	58	2	1102
GeneFamily	EF-hand domain containing	CETN1 CETN2 CABP4 MACF1 RCN3 RYR2	7.06e-05	219	58	6	863
GeneFamily	EF-hand domain containing\|Nucleotide excision repair\|Transcription and export complex 2	CETN2 MCM3AP	1.01e-04	5	58	2	1276
GeneFamily	Calcium voltage-gated channel subunits	CACNA1I CACNA1G	3.13e-03	26	58	2	253
Coexpression	CUI_TCF21_TARGETS_2_DN	RHPN1 STRN ATP7A SPEG KIF1B PSD3 FRS2 MACF1 CARD10 CAVIN1 LYST PGGT1B LDB2	9.97e-06	854	93	13	M1533
Coexpression	CUI_TCF21_TARGETS_2_DN	RHPN1 STRN ATP7A SPEG KIF1B PSD3 FRS2 MACF1 CARD10 CAVIN1 LYST PGGT1B LDB2	1.51e-05	888	93	13	MM1018
Coexpression	GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP	CACTIN WIZ EXD2 KRI1 TUT1 RCN3	6.80e-05	194	93	6	M9980
Coexpression	GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN	BUD23 NET1 MCM3AP TUT1 DENND5A NT5C	7.40e-05	197	93	6	M5760
Coexpression	GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP	FANCI MCM3AP FRS2 KRI1 PIP5K1C RCN3	7.61e-05	198	93	6	M6109
Coexpression	GSE14308_TH2_VS_INDUCED_TREG_DN	LDB1 CSAD FRS2 CLSTN2 ARHGEF4 F2	8.04e-05	200	93	6	M3367
Coexpression	GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP	VHL KRT16 SUPT5H CSAD CARD10 SPAG9	8.04e-05	200	93	6	M9354
Coexpression	GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN	PKIG KRT16 CSAD PSD3 EEF2K DENND5A	8.04e-05	200	93	6	M304
Coexpression	GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP	CRLF3 SVIL MAPKAPK3 NFKBIZ NUDC NLRP5	8.04e-05	200	93	6	M9881
Coexpression	GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP	NEFL SYNE3 NET1 SVIL CACNA1I DENND5A	8.04e-05	200	93	6	M9883
ToppCell	11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high\|Airway / Age, Tissue, Lineage and Cell class	MXRA5 COPZ2 SVIL EMILIN3 TMEM119 CAVIN1 RCN3 LDB2	9.45e-09	197	94	8	9a053a32ff9c3a85ef9a3382453acd619cc48546
ToppCell	droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACTIN NET1 RHBDL1 RUBCN LDB2 LRRC41	2.22e-06	179	94	6	dd94ebe69ade6f51b94058abe066216f0de9feda
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR1 CARD10 CAVIN1 NOS3 LDB2 CCDC85B	2.86e-06	187	94	6	d6765854154557794815514c0aa355bc74b8523e
ToppCell	Entopeduncular-Endothelial\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	PKIG COPZ2 NET1 YAP1 CAVIN1 RCN3	2.95e-06	188	94	6	94774652fd42bad5012356672ffac8b6d2c22d37
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPR1 MYO7B CAVIN1 CPS1 NOS3 LDB2	3.13e-06	190	94	6	d0297d678498e346e56cf95fe9e3db7d3ad3b837
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MXRA5 COPZ2 MAOB SVIL CAVIN1 RCN3	3.43e-06	193	94	6	adc9fc94f9ec686a417d08c0b8b7b7ab687afec0
ToppCell	Control-Non-classical_Monocyte-\|Control / Disease condition and Cell class	CABP4 SVIL SETBP1 MAPKAPK3 NFKBIZ LYST	3.75e-06	196	94	6	b17ab094cdc7050c2997e24ed474779b5d6f6146
ToppCell	Control-Non-classical_Monocyte\|Control / Disease condition and Cell class	CABP4 SVIL SETBP1 MAPKAPK3 NFKBIZ LYST	3.75e-06	196	94	6	404064ccfe2cb73df7a7f88aa65d86b97dcef9d4
ToppCell	Tracheal-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPR1 CABP4 GJC2 TMEM119 CPS1 PIP5K1C	3.86e-06	197	94	6	e91572edbe48d40269ee2cf7c858764cff6985ac
ToppCell	Tracheal-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NPR1 CABP4 GJC2 TMEM119 CPS1 PIP5K1C	3.86e-06	197	94	6	7e3f78a61089d1200cc6b0fa2034bf2998651694
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MAOB YAP1 PSD3 MACF1 TMEM119 RYR2	3.86e-06	197	94	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Mast\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNE3 MAOB CRLF3 EEF2K ENO2	1.72e-05	151	94	5	9702575e47ececcf0a9f0f20a4a920dbb1ba5657
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNE3 MAOB CRLF3 EEF2K ENO2	1.72e-05	151	94	5	673e4ab117b723c14d1df3804bbedc9e48284a9d
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COPZ2 MCM2 GJC2 PIP5K1C LDB2	2.20e-05	159	94	5	c960df9e4fa980401941866b5081facac4590b4d
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_bronchial_vessel-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RHPN1 CETN2 RP1L1 DBNL KRI1	2.71e-05	166	94	5	a697460dfe72e08fbf7d8e734a16b7dd2c6d86f9
ToppCell	Myeloid-Myeloid-D_(Mast_cell)\|Myeloid / shred on cell class and cell subclass (v4)	MAOB CRLF3 MAPKAPK3 NFKBIZ EEF2K	3.12e-05	171	94	5	5f1aafc4c55a9c6c3153430186a8a351425a3cb9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPR1 NET1 SPEG SETBP1 RYR2	3.49e-05	175	94	5	316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NPR1 NET1 SPEG SETBP1 RYR2	3.49e-05	175	94	5	a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RP1L1 RHBDL1 CACNA1G MFSD1 RCN3	3.78e-05	178	94	5	24e8c62060455159235985f456af0c5023a7f3f5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RP1L1 RHBDL1 CACNA1G MFSD1 RCN3	3.78e-05	178	94	5	4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETD2 MACF1 CHD9 NFKBIZ LYST	4.43e-05	184	94	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RHPN1 NET1 DUSP8 CACNA1I CCDC85B	4.43e-05	184	94	5	780d67f04fc795f614e077d8a5cf368542f6d99d
ToppCell	normal-na-Lymphocytic-lymphocyte-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	RNF121 SETD6 CSAD MCM2 LDB2	4.43e-05	184	94	5	2c286712428662bc4589dc5ac4011bf7ed403cb5
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETD2 KRT16 NFKBIZ SPAG9 UTY	4.54e-05	185	94	5	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	Thalamus-Endothelial\|Thalamus / BrainAtlas - Mouse McCarroll V32	PKIG COPZ2 YAP1 CAVIN1 RCN3	4.66e-05	186	94	5	dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb
ToppCell	facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR1 YAP1 CAVIN1 NOS3 LDB2	4.66e-05	186	94	5	5302399825f213d105ac70b91366a4513b732838
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEFL PSD3 CACNA1I ENO2 RYR2	4.78e-05	187	94	5	7b2cd0c618ed081223343f3bec2244c8723c9a31
ToppCell	facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RP1L1 CARD10 CAVIN1 NOS3 LDB2	4.78e-05	187	94	5	7170694a1b86fe8d84d96c880ffe57af09bdc026
ToppCell	Substantia_nigra-Endothelial\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	COPZ2 YAP1 SVIL CAVIN1 RCN3	5.03e-05	189	94	5	bef8234bd9c4d6e3cdef0791d8066b39ba56ebba
ToppCell	10x5'v1-week_12-13-Endothelial-stroma-tip_EC\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	NHSL1 NPR1 CARD10 CAVIN1 LDB2	5.29e-05	191	94	5	cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NEFL NET1 SPEG SVIL RCN3	5.42e-05	192	94	5	93903576dddd8227328e4ced75aa7625eedb9baf
ToppCell	15-Trachea-Endothelial-Endothelial\|Trachea / Age, Tissue, Lineage and Cell class	NPR1 GJC2 CARD10 CAVIN1 LDB2	5.56e-05	193	94	5	6ea0444fc3dc156997129387184e6418947f4b12
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR1 DUSP8 CAVIN1 LDB2 CCDC85B	5.56e-05	193	94	5	ff048e7fbab95d7914f3a636f6f014e7115d63d8
ToppCell	droplet-Lung-nan-21m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR1 DUSP8 CAVIN1 LDB2 CCDC85B	5.56e-05	193	94	5	4893b922e129711d5886bd4f3ee106e9e7065971
ToppCell	15-Trachea-Endothelial\|Trachea / Age, Tissue, Lineage and Cell class	NPR1 GJC2 CARD10 CAVIN1 LDB2	5.56e-05	193	94	5	b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0
ToppCell	droplet-Lung-nan-21m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NPR1 DUSP8 CAVIN1 LDB2 CCDC85B	5.56e-05	193	94	5	ae35c5757a88b02f8b9f94a0af4c3396ca828cc3
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NPR1 CARD10 CAVIN1 LDB2 CCDC85B	5.83e-05	195	94	5	dfc5da514fb34a2c318a5c4c61f44049fa43960e
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MXRA5 COPZ2 TMEM119 RCN3 RYR2	5.98e-05	196	94	5	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	wk_08-11-Endothelial-Blood_vessel_endothelial-Early_cap\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NPR1 CARD10 CAVIN1 LDB2 CCDC85B	5.98e-05	196	94	5	0f00aac6dac699507ce336020b2e96fd192de0be
ToppCell	wk_08-11-Endothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NPR1 CARD10 CAVIN1 LDB2 CCDC85B	5.98e-05	196	94	5	0e545874083fd8e954a49fc397d57a86b081008b
ToppCell	wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	MXRA5 COPZ2 SVIL RCN3 LDB2	5.98e-05	196	94	5	eed9fe83ffc1f79493b70778962a671dd9f481e0
ToppCell	wk_08-11-Endothelial-Blood_vessel_endothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NPR1 CARD10 CAVIN1 LDB2 CCDC85B	6.12e-05	197	94	5	2ed92f942475db6836e48da3c6b8235eb8691c38
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPR1 CAVIN1 LYST NOS3 LDB2	6.12e-05	197	94	5	8437c33e2c4a10a1b95343431e48d5e820b1f742
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPR1 CAVIN1 LYST NOS3 LDB2	6.12e-05	197	94	5	0542badae77d2f606c13cfaf361319495c354351
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR1 CARD10 CAVIN1 NOS3 CCDC85B	6.12e-05	197	94	5	131bc6ef55f467cc802db68daf7e7d757ea64fc6
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 COPZ2 YAP1 TMEM119 RCN3	6.12e-05	197	94	5	2f72fd9a5b6d62c24a95ed2246194ea7458c0f12
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NPR1 COPZ2 TMEM119 CACNA1G RCN3	6.12e-05	197	94	5	3fe665c0277d091290b63f0dd24c0c6536a45309
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR1 CARD10 CAVIN1 NOS3 CCDC85B	6.12e-05	197	94	5	dfc052a447c3b32235fcaffdf06c4e0941723d19
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NPR1 CARD10 CAVIN1 LDB2 CCDC85B	6.12e-05	197	94	5	9b3d6fe76dd7d61a286a28d9466b5f2fece048e1
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NPR1 CAVIN1 LYST NOS3 LDB2	6.12e-05	197	94	5	a6a64581699cfcb9607b288976fa3b09648725b7
ToppCell	3'-GW_trimst-1-SmallIntestine-Endothelial\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR1 CARD10 CAVIN1 NOS3 CCDC85B	6.27e-05	198	94	5	ff8a9adc1302a4679ccdfe9ef95ef53e4c7a5391
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MXRA5 COPZ2 CAVIN1 RCN3 LDB2	6.27e-05	198	94	5	8b9e8eaeffda40912a0163fdf39b93bc5e64751c
ToppCell	tumor_Lung-Fibroblasts-Myofibroblasts\|tumor_Lung / Location, Cell class and cell subclass	MXRA5 COPZ2 TMEM119 CAVIN1 RCN3	6.27e-05	198	94	5	31f9181dab689aabe9c6182c2ef7de65ba3f0ff6
ToppCell	10x5'v1-week_12-13-Endothelial-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	NHSL1 NPR1 CARD10 CAVIN1 LDB2	6.27e-05	198	94	5	122215d9288533ad03562cf777e846504863df9a
ToppCell	metastatic_Brain-Endothelial_cells\|metastatic_Brain / Location, Cell class and cell subclass	NPR1 CAVIN1 NOS3 LDB2 CCDC85B	6.27e-05	198	94	5	97ef7946ef11ac93318c1dd46b548dc01e5a6aba
ToppCell	10x5'v1-week_12-13-Endothelial\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	NHSL1 NPR1 CARD10 CAVIN1 LDB2	6.27e-05	198	94	5	307dd09e6bc820a148f3000f18dae7aedba4be0b
ToppCell	3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NPR1 CARD10 CAVIN1 NOS3 CCDC85B	6.27e-05	198	94	5	4a70a1ab40fe30b90acd97e4e36067db62acc905
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MXRA5 COPZ2 CAVIN1 RCN3 LDB2	6.27e-05	198	94	5	eb78b2ae6a787dbc75947e8dd5a03693285bc8be
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	NPR1 CARD10 CAVIN1 LDB2 CCDC85B	6.27e-05	198	94	5	75270600b5b29187dfa86f01f8f927ae0621cda4
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 COPZ2 YAP1 TMEM119 RCN3	6.42e-05	199	94	5	d65ee89d5c7e8ed693d58e6a6de09565840e11c5
ToppCell	distal-Endothelial-Vein-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NPR1 COPZ2 CAVIN1 LYST NOS3	6.42e-05	199	94	5	f9fc0482d7ab11f2165b30cce3564b4ff87d61a6
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-tip_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NPR1 CARD10 CAVIN1 NOS3 LDB2	6.42e-05	199	94	5	1c69395c9305b6ecb0a826d46c8e8ec95795ad6d
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 MAOB MACF1 TMEM119 RYR2	6.42e-05	199	94	5	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 MAOB MACF1 TMEM119 RYR2	6.42e-05	199	94	5	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 COPZ2 YAP1 TMEM119 RCN3	6.42e-05	199	94	5	bf138cc692df727e087d140c014149ee5da00d9d
ToppCell	Kidney-Endothelial\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	NPR1 CAVIN1 NOS3 LDB2 CCDC85B	6.42e-05	199	94	5	b543f0686522df43737e9ffa5c9733e42b8a9f4d
ToppCell	proximal-Endothelial\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NPR1 CARD10 CAVIN1 NOS3 LDB2	6.58e-05	200	94	5	970dac1b11ae8f4adb26634717064289967b4bde
ToppCell	proximal-3-Endothelial\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NPR1 CARD10 CAVIN1 NOS3 LDB2	6.58e-05	200	94	5	90c36cfb9632a3bdc9a335b2193f6b08aba35208
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	MXRA5 COPZ2 SVIL TMEM119 RCN3	6.58e-05	200	94	5	eabb7d4aa92ace7d970bcd3fae2c7cb5400a43b4
ToppCell	10x5'v1-week_14-16-Endothelial-stroma-tip_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NPR1 CARD10 CAVIN1 NOS3 LDB2	6.58e-05	200	94	5	77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MAOB SETBP1 MACF1 TMEM119 RYR2	6.58e-05	200	94	5	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MYO7B MCM2 PATL1 PIP5K1C LDB2	6.58e-05	200	94	5	a8b59e6fe04271fef61db911a286b5c48438bb84
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPR1 CAVIN1 NOS3 LDB2 CCDC85B	6.58e-05	200	94	5	b1be27d134a8633e3e7862c6a0d7be2001d387f0
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial\|2m / Sample Type, Dataset, Time_group, and Cell type.	MXRA5 SVIL NFKBIZ TMEM119 RCN3	6.58e-05	200	94	5	3da9441c0f1e242f0d195de47ecd4c24dfdca232
ToppCell	distal-3-Endothelial-Vein\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NPR1 CAVIN1 LYST NOS3 LDB2	6.58e-05	200	94	5	3a5c85bad2e7a9ecf55d90acb04178a343b3f5fd
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial-Proteoglycan-expressing_cell\|3m / Sample Type, Dataset, Time_group, and Cell type.	MXRA5 COPZ2 NFKBIZ TMEM119 CAVIN1	6.58e-05	200	94	5	94ef227b2162ba77af33b8cc8aaa4a7e3bdf79a7
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Vein\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	NPR1 NET1 SPAG9 NOS3 LDB2	6.58e-05	200	94	5	b3f93b71589251197cde96b7bc6d065c106f61cd
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MAOB SETBP1 MACF1 TMEM119 RYR2	6.58e-05	200	94	5	a510deaada669e690329183e18df02870bd204b3
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPR1 CAVIN1 NOS3 LDB2 CCDC85B	6.58e-05	200	94	5	dba96cda5f3b780a3d4171b61bc8aaddc1f5d466
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	MXRA5 SVIL NFKBIZ TMEM119 RCN3	6.58e-05	200	94	5	eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NPR1 CAVIN1 NOS3 LDB2 CCDC85B	6.58e-05	200	94	5	7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	NPR1 NET1 LYST NOS3 LDB2	6.58e-05	200	94	5	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial\|3m / Sample Type, Dataset, Time_group, and Cell type.	MXRA5 COPZ2 NFKBIZ TMEM119 CAVIN1	6.58e-05	200	94	5	429028c3112d279b26abf3296e01b1884b4b7fcb
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MAOB SETBP1 MACF1 TMEM119 RYR2	6.58e-05	200	94	5	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	EXD2 MCM2 PIP5K1C RUBCN	1.14e-04	118	94	4	08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698
ToppCell	356C-Epithelial_cells-Epithelial-H_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	EXD2 MCM2 PIP5K1C RUBCN	1.14e-04	118	94	4	3b077ad5c68c01b3fcc93f203cb130bb90705af9
ToppCell	facs-Heart-RV-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPKAPK3 KRI1 ENO2 ZNF513	1.92e-04	135	94	4	99e7ac9b1139fe4ff036f6f048a8f1cc514c1fb9
ToppCell	facs-Heart-RV-24m-Myeloid-macrophage\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAPKAPK3 KRI1 ENO2 ZNF513	1.92e-04	135	94	4	1fe684ed5913ae757ad6befbbe12d1bee481dd12
ToppCell	droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAOB CPS1 F2 PCK1	2.94e-04	151	94	4	cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4
ToppCell	droplet-Liver-nan-3m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAOB CPS1 F2 PCK1	2.94e-04	151	94	4	7758cfbe8dca849c90bd6e8bc63310e53beeb8fd
ToppCell	Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAOB MCM2 TMEM119 RYR2	2.94e-04	151	94	4	32d35906f4b2bd46b173e87f2dec972eb5da87b3
ToppCell	droplet-Liver-nan-3m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAOB CPS1 F2 PCK1	2.94e-04	151	94	4	b4a0546c1573b4b2290890307f2a5daf3a7cbb37
ToppCell	droplet-Liver-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAOB CPS1 F2 PCK1	3.02e-04	152	94	4	1febeeb7376e34b9f86c81b2cb1314ee12408864
ToppCell	droplet-Liver-nan-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAOB CPS1 F2 PCK1	3.02e-04	152	94	4	faa92f7c5a6db9f1eb7d8ec930ba7c8ed9fd1bf1
ToppCell	droplet-Lung-nan-3m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STRN FANCI F2 ENO2	3.02e-04	152	94	4	77b319f594d5e4df29034bbf69c7490076f89dd3
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	NET1 KIF1B SPAG9 RAB41	3.75e-04	161	94	4	347edb0de10850b7d16c40945751033289289c9b
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHBDL1 NFKBIZ CACNA1G LYST	4.02e-04	164	94	4	f9a2cc12179d5621c9174ec01d7418a71edd28d1
ToppCell	COVID-19_Mild-PLT_0\|COVID-19_Mild / Disease Group and Platelet Clusters	SYNE3 MAOB MACF1 RUBCN	4.11e-04	165	94	4	083a14d3b0162cee4e79f7398b8fb739582b39ff
ToppCell	E16.5-Endothelial-Endothelial_lymphatic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPR1 SYNE3 GJC2 LDB2	4.31e-04	167	94	4	b93103a868fba63a8910bffb690a6242b9252833
ToppCell	E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NPR1 SYNE3 GJC2 LDB2	4.31e-04	167	94	4	fcd583b1efd0ac883379982ea8e6c54f2c0be268
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A	STRN ZNF212 MAPKAPK3 FRS2 KRI1 MACF1 RUBCN RYR2	1.67e-06	198	94	8	7323_DN
Drug	themisone	CACNA1I CACNA1G LYST	1.46e-05	12	94	3	CID000016235
Drug	Jolkinolide B	KRT16 ENO2	1.69e-05	2	94	2	CID000161954
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A	SVIL PSD3 FRS2 TUT1 ARHGEF4 LYST RCN3	1.71e-05	196	94	7	4965_DN
Drug	Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A	CACTIN SETD2 WIZ FRS2 TUT1 PIP5K1C RYR2	1.77e-05	197	94	7	7335_DN
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CACTIN STRN COPZ2 WIZ UTY NT5C RCN3	1.83e-05	198	94	7	4367_DN
Drug	Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; HL60; HT_HG-U133A	NPR1 WIZ CETN1 SETBP1 CARD10 CACNA1I LRRC41	1.83e-05	198	94	7	2929_UP
Drug	Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A	STRN SUPT5H SPEG SETBP1 DUSP8 CPS1 RYR2	1.89e-05	199	94	7	5787_DN
Drug	Zonisamide	MAOB CACNA1I CACNA1G	4.44e-05	17	94	3	DB00909
Drug	1,3-dioxoisoindoline-5-carboxamide	CACNA1I CACNA1G	5.05e-05	3	94	2	CID010679219
Drug	vanillylmandelic acid	VHL MAOB KIF1B ENO2	7.91e-05	55	94	4	CID000001245
Drug	N-methyl-DL-aspartic acid	NEFL NPR1 MAOB CSAD RHBDL1 CACNA1I EEF2K CACNA1G ENO2 NOS3 RYR2	8.14e-05	655	94	11	CID000004376
Drug	AC1Q6SH8	CACNA1I SPAG9 F2 PIP5K1C NT5C	1.20e-04	116	94	5	CID000000009
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	STRN CACNA1I CAVIN1 PIP5K1C LYST UTY	1.27e-04	187	94	6	6984_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	STRN SUPT5H SETBP1 PIP5K1C LYST LRRC41	1.34e-04	189	94	6	1206_DN
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; PC3; HT_HG-U133A	SPEG SETBP1 SPAG9 TUT1 CPS1 RCN3	1.38e-04	190	94	6	5080_DN
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	MCM3AP DUSP8 CACNA1I CPS1 LYST RYR2	1.42e-04	191	94	6	5234_DN
Drug	Metergoline [17692-51-2]; Down 200; 10uM; MCF7; HT_HG-U133A	CACTIN WIZ FRS2 KRI1 CAVIN1 RCN3	1.51e-04	193	94	6	3221_DN
Drug	(+,-)-Synephrine [94-07-5]; Up 200; 24uM; MCF7; HT_HG-U133A	CACTIN NPR1 WIZ PSD3 CACNA1I PCK1	1.51e-04	193	94	6	3578_UP
Drug	geldanamycin; Down 200; 1uM; MCF7; HG-U133A	COPZ2 LDB1 CETN1 DUSP8 TUT1 UTY	1.51e-04	193	94	6	593_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	STRN PSD3 KRI1 ENO2 LYST LRRC41	1.51e-04	193	94	6	5239_DN
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A	LDB1 WIZ SVIL CAVIN1 TUT1 RYR2	1.51e-04	193	94	6	7232_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	CACTIN WIZ SPAG9 ARHGEF4 ENO2 RYR2	1.55e-04	194	94	6	4804_DN
Drug	Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A	CACTIN SETD2 LDB1 SEC23IP PIP5K1C LYST	1.64e-04	196	94	6	3271_DN
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	SETD2 LDB1 WIZ SPEG TUT1 RYR2	1.64e-04	196	94	6	4539_DN
Drug	Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A	VHL COPZ2 MCM3AP CAVIN1 CLSTN2 LYST	1.64e-04	196	94	6	5486_UP
Drug	oxyhyponitrite	NPR1 NOS3 RYR2	1.65e-04	26	94	3	CID005491930
Drug	Fendiline	F2 NOS3	1.67e-04	5	94	2	ctd:D005275
Drug	Flunarizine	CACNA1I CACNA1G	1.67e-04	5	94	2	DB04841
Drug	Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A	LDB1 FRS2 CAVIN1 PIP5K1C LYST RYR2	1.68e-04	197	94	6	7227_DN
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A	SETD2 LDB1 MYO7A FRS2 CACNA1I TUT1	1.68e-04	197	94	6	2110_UP
Drug	CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A	COPZ2 MAOB CARD10 CACNA1I UTY CCDC85B	1.68e-04	197	94	6	6369_DN
Drug	Azaperone [1649-18-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A	VHL SETBP1 CARD10 ARHGEF4 CPS1 LYST	1.68e-04	197	94	6	3573_UP
Drug	CO(2	CSAD RHBDL1 CLSTN2 CPS1 F2 ENO2 NOS3 PCK1	1.72e-04	378	94	8	CID000000280
Drug	Astemizole [68844-77-9]; Down 200; 8.8uM; MCF7; HT_HG-U133A	CACTIN WIZ SEC23IP ARHGEF4 PIP5K1C RYR2	1.73e-04	198	94	6	2211_DN
Drug	Asiaticoside [16830-15-2]; Down 200; 4.2uM; HL60; HT_HG-U133A	CACTIN LDB1 SUPT5H SVIL DUSP8 TUT1	1.73e-04	198	94	6	2943_DN
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A	STRN MAOB MYO7A SETBP1 TUT1 CPS1	1.73e-04	198	94	6	6395_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	STRN GJC2 PIP5K1C LYST UTY RYR2	1.73e-04	198	94	6	6969_UP
Drug	Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A	NPR1 WIZ MAOB RHBDL1 CACNA1I NOS3	1.73e-04	198	94	6	2271_UP
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A	CACTIN MYO7A PSD3 PIP5K1C RCN3 RYR2	1.73e-04	198	94	6	2217_DN
Drug	Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; HL60; HG-U133A	CACTIN LDB1 WIZ SUPT5H ZNF212 MACF1	1.73e-04	198	94	6	1576_DN
Drug	Ioversol [87771-40-2]; Up 200; 5uM; MCF7; HT_HG-U133A	CACTIN WIZ SVIL ARHGEF4 PIP5K1C LRRC41	1.73e-04	198	94	6	5326_UP
Drug	ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A	STRN WIZ PIP5K1C ENO2 UTY RCN3	1.73e-04	198	94	6	6965_UP
Drug	Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A	SETD2 STRN LDB1 CACNA1I CAVIN1 LDB2	1.78e-04	199	94	6	3541_UP
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	STRN LDB1 WIZ TUT1 ENO2 NT5C	1.78e-04	199	94	6	3608_DN
Drug	Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	COPZ2 SVIL DUSP8 CAVIN1 LYST LRRC41	1.78e-04	199	94	6	5358_UP
Drug	Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A	CACTIN STRN SVIL MACF1 TUT1 PGGT1B	1.78e-04	199	94	6	2654_DN
Drug	C75; Up 200; 10uM; MCF7; HT_HG-U133A	VHL STRN NPR1 MYO7A CACNA1I CPS1	1.78e-04	199	94	6	6394_UP
Drug	Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A	STRN WIZ SUPT5H CAVIN1 LYST RCN3	1.78e-04	199	94	6	3266_DN
Drug	Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; HL60; HT_HG-U133A	NPR1 COPZ2 LDB1 MCM3AP CACNA1I CACNA1G	1.78e-04	199	94	6	2498_UP
Drug	Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; HL60; HT_HG-U133A	PKIG STRN WIZ PSD3 CACNA1I RYR2	1.78e-04	199	94	6	6153_UP
Drug	Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A	NPR1 MXRA5 WIZ MAOB SPEG PSD3	1.78e-04	199	94	6	5544_UP
Drug	Bupropion hydrochloride [31677-93-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A	CACTIN LDB1 FRS2 CACNA1G ARHGEF4 PIP5K1C	1.78e-04	199	94	6	6256_UP
Drug	U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A	NPR1 SETBP1 PSD3 CACNA1I TUT1 CPS1	1.78e-04	199	94	6	4375_DN
Drug	HA-1077 dihydrochloride; Down 200; 10uM; MCF7; HG-U133A	LDB1 SVIL KRI1 TUT1 F2 PGGT1B	1.78e-04	199	94	6	343_DN
Drug	Bretylium tosylate [61-75-6]; Up 200; 9.6uM; HL60; HT_HG-U133A	PKIG NPR1 WIZ MYO7A CACNA1I CACNA1G	1.83e-04	200	94	6	3057_UP
Disease	Pheochromocytoma, Extra-Adrenal	VHL MAOB KIF1B	1.59e-05	16	92	3	C1257877
Disease	Pheochromocytoma	VHL MAOB KIF1B	2.74e-05	19	92	3	C0031511
Disease	STROKE, ISCHEMIC	F2 NOS3	9.56e-05	5	92	2	601367
Disease	Ischemic stroke	F2 NOS3	9.56e-05	5	92	2	cv:C0948008
Disease	Epithelioid hemangioendothelioma	YAP1 TFE3	9.56e-05	5	92	2	C0206732
Disease	platelet reactivity measurement, thrombus formation measurement	SVIL SETBP1	2.00e-04	7	92	2	EFO_0004985, EFO_0007615
Disease	Leukemia, Myelocytic, Acute	SETD2 FANCI SVIL SETBP1 ENO2	2.13e-04	173	92	5	C0023467
Disease	Embryonal Rhabdomyosarcoma	SETD2 YAP1	2.66e-04	8	92	2	C0206656
Disease	Charcot-Marie-Tooth disease	NEFL KIF1B MCM3AP	3.08e-04	42	92	3	cv:C0007959
Disease	mean platelet volume	SETD2 STRN CRLF3 KIF1B SVIL SETBP1 PSD3 CHD9 CAVIN1 CPS1 NOS3	3.33e-04	1020	92	11	EFO_0004584
Disease	QRS complex, QRS duration	STRN SETBP1 HERPUD2	3.79e-04	45	92	3	EFO_0005054, EFO_0005055
Disease	Posterior Choroidal Artery Infarction	F2 NOS3	5.19e-04	11	92	2	C0887799
Disease	Cerebral Infarction, Left Hemisphere	F2 NOS3	5.19e-04	11	92	2	C0751010
Disease	Anterior Choroidal Artery Infarction	F2 NOS3	5.19e-04	11	92	2	C0751012
Disease	Cerebral Infarction, Right Hemisphere	F2 NOS3	5.19e-04	11	92	2	C0751011
Disease	Subcortical Infarction	F2 NOS3	5.19e-04	11	92	2	C0751014
Disease	Cerebral Infarction	F2 NOS3	5.19e-04	11	92	2	C0007785
Disease	Tachycardia, Ventricular	NOS3 RYR2	5.19e-04	11	92	2	C0042514
Disease	Alzheimer's disease (is_implicated_in)	MAOB MCM2 NOS3 PCK1	7.89e-04	132	92	4	DOID:10652 (is_implicated_in)
Disease	third ventricle volume measurement	LDB1 LDB2	9.83e-04	15	92	2	EFO_0010335
Disease	uridine diphosphate galactose measurement, uridine diphosphate glucose measurement	SVIL HERPUD2	1.27e-03	17	92	2	EFO_0010543, EFO_0010544
Disease	Charcot-Marie-Tooth disease type 2	NEFL KIF1B	1.27e-03	17	92	2	cv:C0270914
Disease	citrulline measurement	RP1L1 CPS1	1.76e-03	20	92	2	EFO_0009777
Disease	Hodgkins lymphoma	ZNF526 CACNA1I CLSTN2	2.17e-03	82	92	3	EFO_0000183
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	DHX38 PSD3 MACF1 CPS1 NUDC	2.20e-03	291	92	5	EFO_0008317, EFO_0020946
Disease	serum gamma-glutamyl transferase measurement	SETD2 STRN SVIL RP1L1 PSD3 CHD9 CPS1 NUDC RYR2	2.21e-03	914	92	9	EFO_0004532
Disease	Hereditary Paraganglioma-Pheochromocytoma Syndrome	VHL KIF1B	2.33e-03	23	92	2	C1708353
Disease	congenital diaphragmatic hernia (biomarker_via_orthology)	ATP7A NOS3	2.54e-03	24	92	2	DOID:3827 (biomarker_via_orthology)
Disease	severe acute respiratory syndrome, COVID-19	MXRA5 MYO7A ZNF212 PSD3 LYST LDB2	2.78e-03	447	92	6	EFO_0000694, MONDO_0100096
Disease	carotid artery intima media thickness	NEFL SYNE3 SVIL PSD3 ARHGEF4 HERPUD2	2.88e-03	450	92	6	EFO_0007117
Disease	HMG CoA reductase inhibitor use measurement	SETD2 DHX38 PSD3 NOS3	2.94e-03	189	92	4	EFO_0009932
Disease	Ischemic stroke, coronary artery disease	WIZ CRLF3 NLRP5	3.01e-03	92	92	3	EFO_0001645, HP_0002140

Protein segments in the cluster

Peptide	Gene	Start	Entry
AVDREIEGDLLLGDM	BUD23	91	O43709
MPGRAEAGEAEEEAG	CARD10	1	Q9BWT7
MVEVGADDDEGGAER	CAVIN1	341	Q6NZI2
GGLEELTDEEMAALG	CCDC85B	6	Q15834
EFEEGMVEGRARGEE	DUSP8	591	Q13202
MVEGRARGEELAALG	DUSP8	596	Q13202
MDGAFLVLDEIVDGG	COPZ2	151	Q9P299
RLDMDGLEVVDLEDG	ARHGEF4	546	Q9NR80
EFGGFELELRGDVEM	NPR1	1026	P16066
ELQEMIDEADRDGDG	CETN2	141	P41208
DSEEEEEEEGMGRGR	CLSTN2	921	Q9H4D0
MRIEEELGDEARFAG	ENO2	411	P09104
EEGKRVAMVGDGIND	ATP7A	1291	Q04656
GRIVDRMDRAGDGDG	RCN3	81	Q96D15
MDGVLADFEAGLLRG	NT5C	11	Q8TCD5
EENGRLLGQMEEEGI	PCK1	51	P35558
MEAGGFGLEAAERTE	RAB41	11	Q5JT25
DVDEGADLLGMGREV	SPAG9	396	O60271
FRMGDEGGESELLGE	SPAG9	1281	O60271
EEDGEELIGDGMERD	MCM2	66	P49736
LVLEDLQDGDVRMGG	NET1	436	Q7Z628
MEGAVEAGERAAREI	MAOB	436	P27338
EGMAGLEGFGQELRE	FHIP1B	666	Q8N612
GNILDMVLREDGEDE	FANCI	1291	Q9NVI1
EQTGNGERDEMDLLG	PATL1	66	Q86TB9
MIVDKLLDDSRGGEG	NFKBIZ	1	Q9BYH8
MEGGELFSRIQERGD	MAPKAPK3	121	Q16644
MGGEFGDEDERLITR	LDB1	346	Q86U70
LGEEEPMLGLGEEEE	GJC2	141	Q5T442
EALLAEMGVAIREDG	KIF1B	506	O60333
GGDAVEKEVEDGLML	MCM3AP	1506	O60318
TLMGGEFGDEDERLI	LDB2	306	O43679
GMSRLGEEVNGEATE	EXD2	296	Q9NVH0
LDGLAREEMDEGGLL	NHSL1	1556	Q5SYE7
AEDLVREGEIAMLGG	CRLF3	106	Q8IUI8
REGEIAMLGGVGEEN	CRLF3	111	Q8IUI8
EEEMLALRGQTGGDV	KRT16	256	P08779
VTGNEMLGLEEGDLE	KRI1	371	Q8N9T8
MEEEDEEARALLAGG	MFSD1	1	Q9H3U5
FDGDDLMVQGLGESE	NLRP5	546	P59047
ADLDDELDGMGAIGR	MACF1	5141	Q9UPN3
DMELDEAGDVIGVLR	NOS3	1136	P29474
EGAREVEMDAVGKDG	CPS1	1171	P31327
GDLVIADGDGQLMEG	CHD9	1756	Q3L8U1
MGGRVDFEEFVELIG	CABP4	181	P57796
ARAGAGEVELADREM	CACNA1G	671	O43497
MEVDAPGVDGRDGLR	C4orf3	1	Q8WVX3
VDDDGNELGSGIMEL	FRS2	26	Q8WU20
FTKMGDRGDRGEDEE	CACNA1I	1106	Q9P0X4
GMDDGSLERILVGEL	DENND5A	1051	Q6IQ26
PEDLERQIGMAEAEG	CSAD	221	Q9Y600
GLDEEFDLEDVRNMG	LYST	2406	Q99698
GEGEGEGEAVLMEED	CACTIN	531	Q8WUQ7
LMDDGLEDESGEDGG	HERPUD2	356	Q9BSE4
MADEDLIFRLEGVDG	EEF2K	1	O00418
AMLEGGVDGLLEGLE	EMILIN3	426	Q9NT22
AGMELGGGEERLPEE	RUBCN	6	Q92622
MADGGEGEDEIQFLR	RYR2	1	Q92736
RVAGTGEGGLEEMVE	DBNL	41	Q9UJU6
GEGGLEEMVEELNSG	DBNL	46	Q9UJU6
MAATEDERLAGSGEG	PGGT1B	1	P53609
EEREALGGMDSRLFG	UTY	41	O14607
MGADEALESELGLGE	STRN	411	O43815
GGGEARAMDEEIVSE	SLC9A6	46	Q92581
GGMVVHSGRREEEEE	SVIL	1861	O95425
EEGLDLGAQMEAARP	SYNE3	596	Q6ZMZ3
DGEEMEIGEVACGAL	LRRC41	426	Q15345
ARGEAIESDDTMGGI	PIP5K1C	366	O60331
DMGELALEGAEGQVE	PKIG	41	Q9Y2B9
MGDLKSGFEEVDGVR	SKIDA1	1	Q1XH10
EMVGEEGAFVIGREE	SETD6	346	Q8TBK2
LDMAVVGGREDLEDL	WIZ	181	O95785
LSIDGEDGIVRMDLD	SUPT5H	1056	O00267
RGIDDNLDEIPDGEM	SEC23IP	426	Q9Y6Y8
MILEERPDGAGAGEE	RHPN1	1	Q8TCX5
MGRVEDGGTTEELED	RHBDL1	1	O75783
MGGEQEEERFDGMLL	NUDC	1	Q9Y266
ELQEMIDEADRDGDG	CETN1	141	Q12798
QELEEGEGSRLGAAM	ZNF513	321	Q8N8E2
LEDILMEEEEGVVGG	TFE3	521	P19532
MEVEGVGEDEDHRGR	SPEG	1581	Q15772
GEAEGDAMAQEREGK	RP1L1	1761	Q8IWN7
AGDGGEDRVEEMVIE	TUT1	681	Q9H6E5
EELGAEEEMEAGRPR	VHL	46	P40337
GTLEGDGMNIEGEEL	YAP1	456	P46937
RVSEEMGGNLGEEVG	DHX38	596	Q92620
GGAAGERELDEVDMS	RNF121	11	Q9H920
DGELEALMENGEGLS	SETD2	1716	Q9BYW2
DDGDMVLGDELDDLL	ZC3H7A	276	Q8IWR0
TEGEAELGTEMLGDL	ZNF212	186	Q9UDV6
EEAMAEVGDDAVGGD	ZNF526	251	Q8TF50
DGRIVEGSDAEIGMS	F2	361	P00734
GGERMEPEEEDELGS	SETBP1	51	Q9Y6X0
GARMVEGRGAEEEEK	TMEM119	196	Q4V9L6
MEEGGEGLRASLEFD	PSD3	66	Q9NYI0
VREDIVEDEGGSGMG	MXRA5	691	Q9NR99
GVEDMIRLGDLNEAG	MYO7A	66	Q13402
GVDDMIRLGDLNEAG	MYO7B	66	Q6PIF6
EDAEGRLMEARKGAD	NEFL	186	P07196